CSOM (Chronic Suppurative Otitis Media) is a disease of the middle ear that causes recurrent discharges from the ear and is characterized by a perforated eardrum that has not healed over a period of three or more months [1]. The usual course of this condition follows a series of acute ear infections which have been poorly treated or lead to chronic inflammation and damage to the structures of the middle ear cavity. Due to CSOM being one of the leading causes of preventable hearing loss across the world, it is a cause of concern for global public health, particularly in developing countries where access to fast diagnosis and treatment is limited [2]. People suffering from CSOM experience persistent ear discharge and hearing problems, which can interfere with communication, performance in school for children, or their general quality of life.
The global impact of chronic suppurative otitis media (CSOM) is predominantly felt by populations living under resource limitations, such as elsewhere in Sub-Saharan Africa and parts of Asia [3]. Various socioeconomic and environmental conditions contribute significantly to the prevalence of CSOM in these regions. Significant risk factors to the development and progression of ear infections include poor sanitation, overcrowded living circumstances, under-nutrition, and limited or no access to healthcare services [4]. Young children who live under these conditions are especially vulnerable due to the developmental stage of their immune systems and the anatomical structure of their Eustachian tubes, making them more likely to develop middle ear infections [5]. Other factors that contribute to the possibility of developing CSOM include recurrent upper respiratory tract infections, inadequate hygiene practices, and exposure to unclean water sources.
Most microbiological studies to date indicate that there are a number of different pathogenic bacteria that are responsible for causing CSOM. These bacteria include, but are not limited to: Pseudomonas aeruginosa, Staphylococcus aureus, Proteus mirabilis, and Klebsiellapneumoniae [6-8]. The nature of their environment (moist and rich in nutrients) provides ideal conditions for bacteria in the middle ear to thrive, particularly when the tympanic membrane has been perforated for an extended period of time, allowing multiple opportunities for the bacteria to invade. Some of these bacteria also produce biofilms, which protect them from the host immune response as well as antimicrobial agents, thus contributing to persistent infection and treatment failure.
Antibiotics remain the primary treatment method for bacterial infections caused by CSOM (which is commonly known as chronic suppurative otitis media). Both topical and systemic antibiotics are often used to manage infection and reduce discharge from the ear. However, the increasing occurrence of antibiotic resistance is presenting a major challenge to clinicians throughout the world and will continue to impact public health systems (9). The overuse or misuse of antibiotics, which includes self-medicating, not completing treatment as directed by a doctor, and purchasing them over the counter without a physician's guidance, is a significant factor contributing to the increased number of resistant bacteria (10). Patients with infections that could previously be treated easily now find it much more difficult to receive effective treatment.
The World Health Organization has stated that antimicrobial resistance is one of the top threats to global health. The excessive use of antibiotics in both community and healthcare settings is one of the leading causes of the emergence and dissemination of resistant pathogens (11). Patients who develop resistant infections suffer from longer recovery times and greater risk of suffering complications, while healthcare systems incur more costs associated with extended hospitalizations and purchasing second-line medications to treat those infections.
The healthcare system in Liberia is plagued by many difficulties in terms of infrastructure, workforce capacity and access to diagnostic technology. In recent years the country has experienced multiple public health crises such as large infectious disease outbreaks which stressed the country’s healthcare system and reduced the ability to conduct routine surveillance of disease [12]. Most healthcare facilities in Liberia have inadequate laboratory infrastructure for the microbiological diagnosis of disease particularly in both small and large urban areas. The inadequate laboratory infrastructure in these regions has created challenges for accurately identifying the types of bacterial pathogens that cause common clinical infections (i.e., chronic suppurative otitis media) as well as monitoring antimicrobial resistance in these pathogens [13].
To effectively manage disease, it is imperative to have an understanding of how antibiotics are typically used and how they are resistant to treatment. Such data can provide physicians with evidence to select the best treatment regimens as well as allow public health officials to use evidence to develop effective management procedures for antibiotics. Additionally, evaluating the knowledge and practices of patients, families, and health service providers will also help to show how behaviors and systems contribute to the inappropriate use of antibiotics [14].
Due to these challenges, there is a demand for integrated work across the fields of community, clinical and health services perspective an in-depth understanding of how CSOM and antibiotic resistant pathogens interact in Liberia. This study will fill this gap by examining patterns of antibiotic resistance associated with bacterial pathogens from chronic suppurative otitis media in three tertiary care hospitals in Liberia, utilizing data gathered from patients, their caregivers and healthcare providers across the country. Anticipated findings will improve methods for managing infections, as well as be used to develop targeted interventions that address the burden of CSOM and antibiotic resistant bacteria in Liberia.
Study Design
The research study that was conducted used a cross-sectional descriptive study design to investigate antimicrobial resistance inthe management of CSOM in Liberia's tertiary healthcare settings. Public health researchers frequently conduct cross-sectional studies to identify the prevalence of various diseases and factors that may contribute to the occurrence of the diseases in populations. The conducted research utilized this design, which allows researchers to collect data from many sources at one time, such as clinical practice sites, health professionals, patients, and caregivers, allowing for examination of data from multiple perspectives. The objective of the conducted research was to identify the overall characteristics and difficulties experienced in the treatment of CSOM in Liberia.
Study Area
A research project took place in Liberia, which is a part of West Africa. The country is developing its health care services and has limited resources available for providing adequate services. The primary focus of the research data collection was tertiary hospitals located in Monrovia or the capital city, as well as other regional health facilities throughout the country where patients were likely to seek targeted care for ear infections and other related ailments. Tertiary facilities are referred to from other institutions and thus receive a high volume of patients who have chronic ear infections such as CSOM. In addition to the hospital-based participants, there were also respondents from the surrounding communities who provided information on their perceptions regarding antibiotic use, how to treat patients with ear infections and the awareness of the potential for developing antimicrobial resistance within the community.
Data Collection
According to this research project structure the researchers have designed and conducted this study by collecting their own data. The researchers have developed a valid instrument to collect the data (questionnaire) to meet the data needs of the study and it includes several sections which contain demographic information, ear infection clinical history, the use of antibiotics, treatment history and knowledge/awareness and drug resistant microbes. Before data collection began the researchers ensured that the instrument was valid for use with the appropriate population by conducting a review to ensure clarity of questions and their relevance to the purpose of study.
In order to conduct a coordinated data collection and meet the required sample size for statistical analysis (n = 945), the researchers recruited 50 community health students from Monrovia who completed orientation and training on the ethical practice of research, how to administer the survey and how to accurately record the responses. The students then administered the survey in different communities and various health care institutions within Liberia and received three types of responses including; patients who had ear infections, care givers for ear infections, and health care workers who treated ear infections.
These coordinated data collections resulted in a total of 945 respondents and reflect a diverse representation of respondents' experiences and perceptions of the management of CSOM and the use of antibiotics from differing geographic regions of Liberia.
Data Analysis
After obtaining all of the information needed to gather data, we reviewed each questionnaire thoroughly for any errors or inaccuracies, and then all of the responses were merged into one database and had to go through a process to remove any discrepancies, errors, or missing responses. We then utilized descriptive analyses to interpret our data.
Using descriptive statistics to summarize the critical demographic information, reported health conditions or symptoms, patterns of antibiotic usage, and levels of knowledge regarding antimicrobial resistance. Researchers were able to identify patterns within the data and present their results as clearly and understandably as possible.
Ethical Considerations
The study strictly adhered to ethical principles guiding ethical research involving humans. Participation in the survey was entirely voluntary, and respondents had full knowledge of the purpose of the research providing that information before they started the questionnaire. All participants provided informed consent for participating in the research before participating. Researchers used no personally identifiable information when collecting data from respondents to protect their confidentiality. All data was anonymised and stored safely, with access to the dataset limited to researchers only. The conducting of research procedures was supported by accepted ethical standards in carrying out research with human subjects [15].
Table 1: Demographic Characteristics of Respondents
|
Age Group |
Male |
Female |
Total |
Percentage |
|
<18 years |
80 |
65 |
145 |
15.3 |
|
18–29 years |
150 |
135 |
285 |
30.2 |
|
30–39 years |
120 |
110 |
230 |
24.3 |
|
40–49 years |
95 |
80 |
175 |
18.5 |
|
≥50 years |
60 |
50 |
110 |
11.7 |
A demographic breakdown of the respondents shows that they form an overall younger population, with equal male-to-female ratios in all age categories. Young adults from 18-29 years make up the highest proportion of the sample (30.2%); thus, young adults are confirmed as the sample’s largest demographic group. Individuals from 30-39 also represented a high percentage (24.3%); therefore, individuals who are actively engaged in their economies were fairly well represented. Moderate representation of respondents is found in the 40-49 year (18.5% - an older adult group) and <18 year (15.3% - a younger adult group) age categories, while those aged ≥50 years have the lowest frequency of representation (11.7%); therefore, the number of older adults present in this study is limited.
In all age groups, there are slightly more males than females, but the differences are generally small, so gender representation is fairly consistent across the sample. For example, in the largest age category (18-29 years), the number of males (150) and number of females (135) are similar.
Therefore, based on data analysis, it can be concluded that the study population consists predominantly of young to middle-aged adults (good gender balance), thus allowing for the findings to be generalised to the working and reproductive-age populations. However, the sample is limited in its representational capacity for older-aged individuals.
Table 2: Reported Symptoms and Clinical History of CSOM
|
Symptom |
Frequently Reported |
Occasionally Reported |
Rarely Reported |
Not Reported |
Total |
|
Ear discharge |
520 |
250 |
90 |
85 |
945 |
|
Hearing loss |
420 |
300 |
120 |
105 |
945 |
|
Ear pain |
350 |
310 |
150 |
135 |
945 |
|
Foul-smelling discharge |
380 |
290 |
130 |
145 |
945 |
|
Recurrent infections |
400 |
280 |
140 |
125 |
945 |
Chronic and recurrent symptoms were common among participants with chronic Suppurative Otitis Media (CSOM) as evidenced by the majority of participants reporting these symptoms either "frequently" (thus) or "occasionally". One of the most common symptoms reported by participants was ear discharge, which is considered the leading clinical feature of CSOM; 520 participants reported this symptom frequently while only 85 reports no ear discharge, reinforcing its centrality to the diagnosis of CSOM.
Hearing loss is also very common among participants, with a total of 720 participants (combined total of frequent and occasional reports) reporting hearing loss; CSOM has a significant effect on an individual's hearing ability and thus, quality of life.
While relatively lower in incidence, compared to the number of individuals who have experienced ear pain infrequently (310); infrequently (150) versus frequently (350), we see that ear pain may not consistently present as a chronic manifestation of patients with CSOM.
Of the 380 who experienced frequent foul-smelling discharge from the ear; and 290 people occasionally (usually indicating either continued or poor resolution of infection), the presence of foul-smelling discharge is an indication of the severity of the underlying process.
Recurrent ear infections continue to be very common among survey respondents exhibiting the chronic and relapsing nature of CSOM, along with the challenges associated with effective treatment options and the potential for antimicrobial resistance. At least 400 respondents have reported experiencing frequent recurrence of ear infections, which emphasizes this point even further.
The findings of the survey demonstrate that the most common and persistent clinical features experienced by those with CSOM are ear discharge, hearing loss, and recurrent infections; whereas ear pain was most variable. This supports the notion that CSOM is a chronic disease, and therefore requires improvements in long-term management; whether through improved new therapeutic options, better diagnostic methods, or better education regarding treatment options.
Table 3: Antibiotic Usage Among Respondents
|
Antibiotic |
Doctor Prescription |
Self-Medication |
Both |
Not Used |
Total |
|
Amoxicillin |
260 |
210 |
90 |
385 |
945 |
|
Ciprofloxacin |
180 |
150 |
70 |
545 |
945 |
|
Gentamicin |
120 |
80 |
60 |
685 |
945 |
|
Erythromycin |
140 |
160 |
70 |
575 |
945 |
|
Ceftriaxone |
160 |
70 |
45 |
670 |
945 |
Respondents showed a wide range in patterns of antibiotic use which included a combination of doctor prescribed antibiotics and self-medicated antibiotics in the analysed data in Table 3. Amoxicillin was the most frequently used antibiotic because 260 out of 615 respondents used it by prescription from a doctor while 210 self-medicated with amoxicillin. These high numbers suggest that amoxicillin is readily available for use and is commonly used by patients who are being treated for CSOM. However, it should be noted that 385 of the respondents did not use amoxicillin which suggests that there was differential treatment choice among the study population. The second most used antibiotic was ciprofloxacin as 180 respondents received prescription of the drug from a physician and 150 self-medicated with it. However, 545 also indicated that they did not use ciprofloxacin at all. Other alternatives to amoxicillin and ciprofloxacin such as gentamicin and ceftriaxone demonstrated very low utilization rates among all respondents as the majority used neither drug (685 for gentamicin and 670 for ceftriaxone) likely due to limited access or the need for clinical use. In analysing erythromycin, there seemed to be evidence of potential misuse due to the fact that 160 respondents used erythromycin via self-medication whereas only 140 respondents had been prescribed erythromycin.
Moreover, reported use of prescribed and self-treated antibiotics among survey participants in each of the four categories shows a tendency to overlap their usage patterns, resulting in increased potential for both incorrect dosing and resistance to antimicrobial agents; thus highlighting the overall level of dependence upon most widely available antimicrobials, the amount of self-medications performed, and only using limited numbers (if even) of specialized antimicrobials as reasons to promote better overall stewardship and requirement for improved regulation regarding the management of CSOMs.
Table 4: Stakeholder Awareness of Antimicrobial Resistance
|
Awareness Level |
Patients |
Caregivers |
Healthcare Workers |
Community Leaders |
Total |
|
High |
60 |
55 |
120 |
45 |
280 |
|
Moderate |
140 |
120 |
110 |
75 |
445 |
|
Low |
200 |
180 |
60 |
80 |
520 |
|
Very Low |
90 |
80 |
25 |
35 |
230 |
|
No Awareness |
50 |
40 |
10 |
20 |
120 |
Table 4 shows a general lack of knowledge about antimicrobial resistance (AMR) from the various stakeholders. As shown in the figure below, the majority of the total number of respondents that fell into the low (520) and moderate (445) categories, while the remainder of the respondents - high (280). Also, a significant number of participants identified themselves as not aware (120), indicating a substantial knowledge gap with regard to AMR.
Among the various groups of people sampled, healthcare workers had a relatively higher level of awareness compared to the other groups. The number of healthcare workers surveyed that reported being high awareness of AMR = 120, while those reporting low and very low were 60 and 25 respectively, suggesting that they have received more information about AMR. However, most patients (200) and caregivers (180) reported little or no awareness of AMR, which limits the understanding of people who are directly involved in the treatment of patients. Community leaders appeared to be more split in their awareness as there were almost equal numbers of community leaders who fell into the moderate category (75) as compared to those in the low (80). Generally, the community leaders have demonstrated that they were aware of AMR, but not at a sufficient level to effectively advocate for their respective communities.
The results show high levels of unawareness of Anti-Microbial Resistance (AMR) among respondents across all groups (especially patients [50] and caregivers [40]), which raises concern regarding the existing public health education and communication deficiencies. Although the majority of healthcare workers appear to be more knowledgeable than patients, caregivers and community leaders regarding AMR, they still demonstrate low levels of awareness compared to the general population. A lack of awareness regarding AMR among all groups may also contribute to inappropriate prescribing of antibiotics and the spread of AMR. In summary, the need for increased educational interventions targeted toward AMR and establishing improved awareness campaigns among all parties involved is critical.
This research has revealed some very significant findings regarding the use of antibiotics, as well as the awareness of antimicrobial resistance in stakeholders responsible for managing chronic suppurative otitis media (CSOM) in Liberia. Among respondents, persistent discharge from the ear and varying levels of hearing loss were the most common symptoms reported. This is consistent with previous studies conducted on developing countries where CSOM continues to be a significant source of chronic ear disease and preventable hearing loss [16]. The continued presence of ear discharge is often indicative of an ongoing infection of the middle ear cavity which could lead to physical damage to the tympanic membrane (TM) and other structures surrounding it if not treated properly. Additionally, in many instances, delays in diagnosis or treatment also contribute to the persistence and recurrence of symptoms.
According to survey results from participants, there is still a high prevalence of antibiotic use as antimicrobial therapy remains the most commonly used treatment for ear infections. Although antibiotics have been highly appropriate for management of bacterial infections and for symptom relief associated with CSOM, a high percentage of respondents stated that they have engaged in self-medication with no medical supervision. This trend is well established in many developing nations where antibiotics can commonly be purchased through whether from pharmaceutical stores, informal drug sales or through leftover prescriptions from past treatments [17]. Generally a lack of strict regulatory control of antibiotic distribution leads many users to utilize antimicrobials on their own discretion or from the advice of non-medical professionals.
Antibiotic self-treatment can lead to major medical and public health problems. Antibiotics used incorrectly expose bacterial pathogens to subtherapeutic concentrations of antimicrobial agents through inappropriate drug type, incorrect dosing or adherence to full course of treatment. Continuing to expose bacteria in this manner leads to the potential for resistant bacterial strain "survival" and "proliferation." In turn, repeated exposure to these types of environments subsequently leads to accelerated development of antimicrobial resistance, where it becomes increasingly difficult to treat an infection [18]. Survivors of chronic suppurative otitis media (CSOM) may experience further prolonged illness, repeated episodes of infection and additional complications such as hearing loss.
Providers of health care who took part in this research also voiced their worry about the diminishing efficacy of numerous antibiotic prescriptions used by practitioners today. Clinical evidence taken from various geographical areas as well as laboratory evaluations have reported to the medical provider some degree of increasing resistance among bacterial pathogens associated with CSOM (Chronic Suppurating Otitis Media) (19). Particularly, both Pseudomonas aeruginosa and Staphylococcus aureus have been reported, in different publications, to be developing multiple levels of resistance against many of the commonly prescribed antimicrobial drugs used today (19). Both of these pathogens, due to their ability to remain viable in a moist environment and possess numerous methods of resistance development, will likely result in the need for health care providers to find alternative, more expensive or less available second-line drugs as the resistance level in the bacterial community continues to substantively increase.
Additionally, this research provided insight into the limited knowledge community members have regarding antimicrobial resistant infections. On average, a majority of the respondents have only a minimal or a very basic understanding of how improper use of antibiotics could develop resistant infections. Individuals who lack knowledge concerning the appropriate use of antibiotics frequently discontinue antibiotic therapy prematurely, when their symptoms decrease, and/or use antibiotics for other conditions that do not require the use of an antimicrobial agent. As a result, community education and community awareness of "responsible" antibiotic use need to be significantly improved through public health education programs and other public health initiatives ([20]).
Improved diagnosis capabilities at all levels of healthcare will be key elements in improving management of CSOM; establishing access to accurate microbiological testing provides clinicians the ability to characterize which pathogen causes the infection as well as assess its susceptibility to various antibiotics. Accurate assessment of the pathogen’s susceptibility is fundamental to providing the clinician with accurate information to determine appropriate limited use of antimicrobials (e.g., narrow-spectrum) rather than relying on empirical therapy. In addition, the establishment of laboratory coordinated surveillance systems will allow for monitoring changes in antimicrobial resistance patterns and provide the evidence to support the establishment of national clinical guidelines and antimicrobial stewardship policies [21]. Together, these changes will allow for enhancements in CSOM management, as well as combat the increasing risk associated with more infections becoming resistant to treatment options due to antibiotic misuse.
This report furnished significant information regarding how antibiotics are being prescribed or used as well as information regarding awareness of antimicrobial resistance by those having to provide care or treatment to people with chronic suppurative otitis media (CSOM) in Liberia. Results showed that healthcare providers frequently prescribe antibiotics to patients with ear infections who may have no quality medical supervision prescribed with antibiotics such as using antibiotics by themselves while treating their ear infections and that patients often do not complete their prescribed antibiotic course. The evidence points toward a lack of appropriate, rational use of antibiotics by these important stakeholders and the inappropriate prescribing or use of antibiotics could facilitate the development and dissemination of resistant organisms. Concerns exist with this type of issue in other countries which are developing, where accessibility to antibiotics is more readily available and regulatory oversight is very limited, thus providing a fertile environment for indiscriminate use of(full course) antibiotics. [17][18].
Repeated discharge from your ear, the frequent occurrence of infections and a diminished ability to hear have been identified as the most frequently observed signs of CSOM within this research study. These signs are directly attributable to the presence of chronic inflammation in the middle ear caused by previous cases of treated or unresponsive infections. In addition to causing disruptions to an individual’s ability to function, chronic ear infections can result in long-term adverse effects on an individual’s speech and/or developmental processes; ie, children may develop delays in their ability to speak and/or have difficulty hearing as a result of delays in effective treatment [2,16]. In addition, the continued presence of these signs in the individuals who completed the survey may reflect delays in diagnosing the type of infection they had, as well as inappropriate selection of antibiotics to treat their condition as well as developing new types of bacteria that resist current antibiotics.
One of the most troubling outcomes of this research was the apparent lack of understanding among the community as well as some non-specialists on the seriousness of antimicrobial resistance. Many respondents did not have a clear understanding about the risks of using antibiotics incorrectly, including self-medicating; stopping their treatment before it was complete; and using antibiotics for a condition that probably wouldn't require antibiotic treatment. A lack of understanding about AMR causes people to engage in unsafe medication use and also creates prerequisites for the continued emergence of resistant pathogens, which represents a serious public health challenge. The World Health Organization has highlighted the importance of increasing public understanding of AMR and of promoting appropriate antibiotic use as part of larger, global initiatives to combat this growing public health threat [11].
Healthcare workers managing CSOM have also raised concerns about the decreasing effectiveness of some of the most commonly used antibiotics. Earlier studies have demonstrated increased resistance among organisms that are repeatedly used as pathologic agents in CSOM, including Pseudomonas aeruginosa and Staphylococcus aureus [19]. These organisms are unusually resilient to environments that would normally be damaging to them, and have taken on adaptive traits that enable them to escape from the effects of antimicrobials, which tend to result in longer periods of infection and increased treatment failures.
To meet the increasing obstacles posed by antimicrobial resistance in the management of CSOM there must be coordinated multi-level interventions throughout the entire health care system. Strengthening antimicrobial stewardship programs (ASP) is a crucial means of encouraging rational prescribing behaviour and ensuring that antibiotics are used only when clinically justified. ASP will assist clinicians in the selection of the appropriate antimicrobial(s) ; determining the optimum length of treatment ; and reducing the collection of needless antibiotic exposure [21].
In addition, improving laboratory diagnostic capacities in tertiary care facilities is essential for effective management of infections. Health care professionals' access to credible microbiological testing will enable them to use evidence-based medicine (EBM) to identify the infectious agent/s (pathogen/s) and establish their susceptibility patterns to antibiotics. EBM results in improved clinical outcomes and decreased likelihood of developing antimicrobial resistance to the infectious agent/s being treated.
Furthermore, there should be an emphasis on community-based education & awareness initiatives that provide individuals with knowledge about how to properly use antibiotics and adhere to their prescribed treatment plans. For example, promoting the responsible use of antibiotics through patient-, caregiver- and community healthcare worker-led educational campaigns can also help support the global movement to reduce antimicrobial resistance [20].
In general, this study illustrates that there is an immediate need for a national-level integrated public health strategy to improve antibiotic stewardship, enhance diagnostic capacity and develop awareness in order to reduce the impact of chronic suppurative otitis media (CSOM) and combat the growing threat of AMR in Liberia and similar healthcare systems.
Take-Home Message
Liberia is currently facing a major public health crisis due to the high prevalence of Chronic Suppurative Otitis Media (CSOM), a condition characterized by frequent infections that result in hearing loss or impairment. The emergence of resistant strains of bacteria related to chronic suppurative otitis media (CSOM) continues to be exacerbated by the misuse and self-medication of antibiotics amongst the Liberian population, with little public awareness of antimicrobial resistance (AMR). To limit the AMR associated with CSOM and improve patient outcomes, it is essential to establish effective antimicrobial stewardship programs, strengthen diagnostic capabilities and implement community-wide educational initiatives regarding CSOM prevention and management.
The concept for this research was developed by Dr. Stephen Monday, who also performed a literature review and drafted the manuscript. Professor GimbasonMairafi Daniel contributed to the study design, data interpretation and critical assessment of the manuscript. Babatunde A. Adeyemi provided assistance with data collection, analysis and editing of the manuscript. All authors read and approved the final version of the manuscript.
The authors declare that there are no conflicts of interest regarding the publication of this article.
Disclaimer
The authors express personal opinion(s). The views presented here do not coincide with the official policy or position of any affiliated organization/institution. The data presented represents Author’s personal use and author accepts full responsibility for ensuring the accuracy and integrity of said data.
[1] Acuin J. Chronic suppurative otitis media. BMJ Clinical Evidence. 2004;2004:0507.
[2] Monasta L, Ronfani L, Marchetti F, Montico M, VecchiBrumatti L, Bavcar A, et al. Burden of disease caused by otitis media: systematic review and global estimates. The Lancet Infectious Diseases. 2012;12(10):757–766.
[3] World Health Organization. Chronic suppurative otitis media: burden of illness and management options. Geneva: World Health Organization; 2004.
[4] Rovers MM, Schilder AGM, Zielhuis GA, Rosenfeld RM. Otitis media. The Lancet. 2004;363(9407):465–473.
[5] Schilder AGM, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP, et al. Otitis media. Nature Reviews Disease Primers. 2016;2:16063.
[6] Brook I. Microbiology and management of chronic suppurative otitis media in children. Journal of Tropical Pediatrics. 2008;54(5):341–347.
[7] Roland PS, Stroman DW. Microbiology of chronic suppurative otitis media. Otolaryngologic Clinics of North America. 2002;35(4):783–794.
[8] Kenna MA. Recurrent and chronic otitis media. Pediatric Infectious Disease Journal. 2010;29(12):1113–1114.
[9] Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews. 2010;74(3):417–433.
[10] Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015;40(4):277–283.
[11] World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015.
[12] Republic of Liberia Ministry of Health. National health policy and plan 2011–2021. Monrovia: Ministry of Health; 2011.
[13] Tuckman J. Health systems strengthening in West Africa: challenges and opportunities. Global Health Journal. 2016;4(2):45–52.
[14] Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries: part I: recent trends and current status. The Lancet Infectious Diseases. 2005;5(8):481–493.
[15] Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701–2711.
[16] Lasisi AO, Olaniyan FA, Muibi SA, Azeez IA, Abdulwasiu KG, Lasisi TJ, et al. Clinical and demographic risk factors associated with chronic suppurative otitis media. International Journal of Pediatric Otorhinolaryngology. 2007;71(10):1549–1554.
[17] Ocan M, Obuku EA, Bwanga F, Akena D, Richard S, Ogwal-Okeng J, et al. Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health. 2015;15:742.
[18] Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases. 2013;13(12):1057–1098.
[19] Ahmed A, Usman J, Hashim R. Isolates from chronic suppurative otitis media and their antimicrobial sensitivity pattern in a tertiary care hospital. Journal of Infection in Developing Countries. 2014;8(2):147–152.
[20] Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Frontiers in Public Health. 2017;5:47.
[21] Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016;387(10014):176–187.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications